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We investigated ertapenem-susceptible and -resistant extended-spectrum -lactamase-producing Enter-
obacter cloacae isolates obtained from the same patient. Gene transcription of OmpD and OmpF was dimin-
ished in the ertapenem-resistant isolate. An efflux pump inhibitor decreased the MICs of ertapenem in the
resistant strain, suggesting a potential role of efflux pumps in ertapenem resistance.
Ertapenem is typically active in vitro against the Enterobac-
teriaceae (12). Elevated ertapenem MICs in Klebsiella pneu-
moniae have been associated with extended-spectrum -lactam-
ase or AmpC production and deficiency in the expression of
outer membrane proteins OmpK35 and OmpK36 (3, 4). In this
report, we have studied the antibiotic resistance mechanisms in
a clinical isolate of Enterobacter cloacae exhibiting ertapenem
resistance and compared them to those of a prior ertapenem-
susceptible isolate from the same patient.
A 55-year-old male developed bacteremia due to E. cloacae
(strain ES24), thought to be secondary to an infected dialysis
catheter. The catheter was removed, and imipenem and ami-
kacin were administered for 3 weeks. The patient did not
receive ertapenem. Two weeks after discontinuing the antibi-
otics, blood cultures again grew E. cloacae (strain ER24),
thought to be related to an infection of a new dialysis catheter.
The MICs of various antibiotics were determined by Etest
on Mueller-Hinton agar, with and without 40 g/ml phenylala-
nyl arginyl -naphthylamide (PAN) (Sigma, St. Louis, MO),
an antibiotic efflux pump inhibitor. Characterization of the
strains by analytical isoelectric focusing; detection and se-
quencing of blaCTX-M, blaAmpC, blaTEM and blaSHV genes; as-
sessment of nitrocefin hydrolysis by total cell lysate; assessment
of -lactamase induction; plasmid profile analysis; and pulsed-
field gel electrophoresis were performed by previously de-
scribed methods (9, 11, 13–15).
Real-time reverse transcriptase PCR (RT-PCR) was per-
formed to determine the expression of ompD and ompF porin
genes and the acrB efflux pump gene relative to the rpoB
housekeeping gene. Total RNA was isolated using the RNeasy
kit (QIAGEN Inc., Valencia, CA) and treated with RNase-free
DNase I. The concentration of the RNA was determined spec-
trophotometrically. One hundred twenty-five micrograms of
RNA was reverse transcribed into single-stranded cDNA using
the High Capacity cDNA Archive kit (Applied Biosystems,
Foster City, CA). The cDNAs were subsequently quantified by
real-time PCR amplification with primers specific to the outer
membrane protein (OMP) and efflux pump genes (Table 1)
using the ABI 7300 RealTime PCR system (Applied Biosys-
tems, Foster City, CA) with initial incubations of 50°C for 2
min and 95°C for 12 min, followed by 40 cycles of 15 s at 95°C
and 60 s at 60°C. Expression level results were standardized
relative to the transcription levels of rpoB (housekeeping gene)
for each isolate. The relative change in gene expression for the
ompD, ompF, and acrB genes in the ER24 strain was calculated
as the ratio of ES24 (reference) to ER24 (target) using the
2CT method, where CT is the cycle threshold (8).
Strain ES24 was susceptible to carbapenems (ertapenem
MIC, 2 g/ml; imipenem and meropenem MICs, 0.25 g/ml),
whereas ER24 had higher carbapenem MICs (ertapenem, 32
g/ml; imipenem, 4 g/ml; and meropenem, 6 g/ml). In the
ES24 strain, the PAN had minimal effect on the MIC of all
antibiotics except ciprofloxacin (MIC decreased from 32 to 2
g/ml (Table 2). In the ER24 strain, the presence of PAN
decreased the MICs of ciprofloxacin (from 32 to 3 g/ml),
meropenem (from 6 to 0.75 g/ml), and ertapenem (from 32
to 12 g/ml) (Table 2).
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TABLE 1. Primers used in real-time RT-PCR




rpoB (F) CAGCCGCGAYCAGGTTGACTACA 60 63
rpoB (R) GACGCACCGACGGATACCACCTG
ompD (F) AGAATTTGGCGGCGACACCTAC 60 145
ompD (R) TGCGCTACCGTTTTTACCCTGATA
ompF (F) CCGGCGTGAGCGATAACTTCTTCT 60 136
ompF (R) AACGCATCGGTACGCTCATTTTTG
acrB (F) TCCGGGCGCAGAGAACAAGGTAGA 60 100
acrB (R) TGCGGGCAGGTTAAAGGCGAAGAC
a F, forward primers; R, reverse primers.













By analytical isoelectric focusing, both ES24 and ER24 had
four bands with isoelectric points of 5.4, 7.0, 7.6, and 9. Each
strain harbored blaTEM-1, blaSHV-7, blaSHV-30, and blaMIR (14).
The profiles of plasmid DNA isolated from ES24 and ER24
were identical, and the pulsed-field gel electrophoresis pat-
terns of the two strains were indistinguishable.
The beta-lactamases of both ES24 and ER24 led to relatively
little hydrolytic activity of nitrocefin, when in the uninduced
state (hydrolytic activities of 10 and 20 M/s/mg total protein,
respectively). However, when induced by the presence of ce-
foxitin, hydrolytic activity increased substantially to 290 and
140 M/s/mg total protein, respectively. The transcription lev-
els of the ompD and ompF genes were 11 and 55 times lower,
respectively, in the ertapenem-resistant ER24 isolate com-
pared to the susceptible ES24 (Table 3). The transcription
levels of the acrB gene were equivalent in the two strains (1.2
times higher in ER24 than ES24).
In this report, we investigated an ertapenem-resistant E. clo-
acae blood culture isolate, compared to an earlier ertapenem-
susceptible isolate from the same patient. Although there was
slightly higher -lactamase production by the ertapenem-
resistant isolate, there were no differences in the number or
type of -lactamases between the two strains. However, the
ertapenem-resistant isolate had decreased amounts of RNA
transcripts of the ompF and ompD genes compared to the
ertapenem-susceptible isolate. A notable feature of our
study is that we used RT-PCR to determine the expression
levels of the porin transcripts. This method potentially elim-
inates some of the difficulties associated with subjective
interpretation of outer membrane protein profiles.
It has been previously shown that reduced outer membrane
permeability and high-level cephalosporinase production can act
in combination in clinical isolates of E. cloacae to confer carbap-
enem resistance (1, 5, 6). No phenotypic evidence of efflux pump
overexpression in ertapenem-resistant strains has been found (4).
However, when we used PAN, an efflux pump inhibitor, we
found that the ciprofloxacin, ertapenem, and meropenem MICs
decreased substantially. Ciprofloxacin and meropenem are
known substrates of efflux pumps (10), but ertapenem is not
known as an efflux pump substrate. Several previous studies have
investigated the role efflux pumps (notably the AcrAB pumps)
play in antibiotic resistance in Enterobactericaeae (2, 7). We could
not detect any difference in the expression level of AcrB between
the ertapenem-susceptible and -resistant strains. Based on these
results, we speculate that there is an additional unknown efflux
pump influencing ertapenem resistance.
It must be recognized that while the PAN effect supports
the existence of an efflux pump, it does not necessarily
indicate pump overexpression. Efflux pump-mediated resis-
tance in absolute terms is determined in part by the perme-
ability of the outer membrane. The decreased amounts of
RNA transcripts of the ompF and ompD genes suggest that
the outer membrane of the ertapenem-resistant isolate was
less permeable than that of the susceptible strain—poten-
tially this could lead to higher resistance provided by a pump
without necessarily requiring overexpression per se. There-
fore, although certainly possible, we have not been able to
show direct evidence to actually support pump overexpres-
sion. Further investigations into the nature of the purported
efflux pump and its expression are ongoing.
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